eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | intestinal disease |
| Comorbidity | C0002871|anemia |
| Sentences | 16 |
| PubMedID- 19815838 | We investigated the prevalence and pathogenesis of anemia in patients with inflammatory bowel disease. |
| PubMedID- 19834803 | Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease. |
| PubMedID- 25797377 | [management of anemia in patients with inflammatory bowel disease]. |
| PubMedID- 25893440 | Nausea, weight loss, anemia, history of in inflammatory bowel disease, etc.), the likelihood of an abnormal finding increased to a level that was not different from those who received vce for other indications (27.1%, p = 0.10). |
| PubMedID- 25509205 | Belgian recommendations for the management of anemia in patients with inflammatory bowel disease. |
| PubMedID- 22736141 | [research progress of anemia associated with inflammatory bowel diseases]. |
| PubMedID- 20533591 | Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. |
| PubMedID- 24713758 | The pathophysiological background of anemia in patients with inflammatory bowel disease (ibd) has been established to represent two main types: iron deficiency anemia (ida) and anemia of inflammation, or anemia of chronic disease (acd), with the former being the most prevalent and common [1,2]. |
| PubMedID- 23078888 | Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. |
| PubMedID- 25545376 | Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. |
| PubMedID- 24718943 | [prevalence and management of anemia in patients with inflammatory bowel disease]. |
| PubMedID- 23766655 | Iron deficiency anemia in patients with inflammatory bowel disease. |
| PubMedID- 22419860 | 1 it is the most common type of anemia associated with inflammatory bowel disease (ibd), which affects approximately 33% of sufferers, particularly in conjunction with acute exacerbation of the disease in which bleeding is common. |
| PubMedID- 25900645 | Objective: iron isomaltoside 1000 (monofer(r)) is a high-dose intravenous (iv) iron, which in a recent 8 weeks trial in inflammatory bowel disease (ibd) subjects with iron deficiency anemia (ida) demonstrated good tolerability and efficacy. |
| PubMedID- 25326048 | Background: the treatment of iron deficiency anemia in children with inflammatory bowel disease is a particular challenge and often insufficient. |
| PubMedID- 24760213 | This study aimed to: 1) determine the prevalence of anemia among patients with inflammatory bowel disease; 2) investigate whether routine laboratory markers are useful for diagnosing anemia; and 3) evaluate whether any association exists between anemia and clinical/laboratory variables. |
Page: 1